Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
Nexstim Oyj
NXTMHNexstim Plc, a medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company's navigated transcranial magnetic stimulation (nTMS) technology utilizes 3D navigation for providing accurate and personalized targeting of the TMS to the specific areas of the brain. It also offers Navigated Brain Therapy system, a navigated brain therapy system for the treatment of major depressive disorder (MDD) and chronic neuropathic pain; and Navigated Brain Stimulation (NBS) system, a navigated TMS system for pre-surgical mapping of the speech and motor cortices of the brain. The company primarily markets and sells its diagnostics systems to universities and teaching hospitals. Nexstim Plc was incorporated in 2000 and is headquartered in Helsinki, Finland. Address: ElimAeenkatu 9 B, Helsinki, Finland, 00510
Analytics
Zielpreis von Wall Street
3.77 EURKGV
–Dividendenrendite
–Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Schlüsselzahlen NXTMH
Dividenden-Analyse NXTMH
Dividendenwachstum über 5 Jahre
–Kontinuierliches Wachstum
–Ausschüttungsquote 5-Jahres-Durchschnitt
–Verlauf der Dividende NXTMH
Bewertung der Aktie NXTMH
Finanzen NXTMH
Ergebnisse | 2019 | Dynamik |